| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/JTO.0B013E31816DE2B8 |
| P698 | PubMed publication ID | 18448996 |
| P2093 | author name string | Kari Chansky | |
| Peter Goldstraw | |||
| Jean-Paul Sculier | |||
| John J Crowley | |||
| Jan Van Meerbeeck | |||
| International Staging Committee and Participating Institutions | |||
| P433 | issue | 5 | |
| P304 | page(s) | 457-466 | |
| P577 | publication date | 2008-05-01 | |
| P1433 | published in | Journal of Thoracic Oncology | Q2448056 |
| P1476 | title | The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition | |
| P478 | volume | 3 |
| Q40349242 | A phase II study of carboplatin plus weekly paclitaxel with bevacizumab for elderly patients with non-squamous non-small-cell lung cancer (NEJ016). |
| Q34991328 | A retrospective study of risk and prognostic factors in relation to lower respiratory tract infection in elderly lung cancer patients |
| Q36338248 | A systematically structured review of biomarkers of dying in cancer patients in the last months of life; An exploration of the biology of dying |
| Q35771994 | Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research |
| Q88818061 | An overview of mortality & predictors of small-cell and non-small cell lung cancer among Saudi patients |
| Q34552929 | Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system |
| Q58050577 | Apoptosis Gene Expression Profile in Early-Stage non Small Cell Lung Cancer |
| Q47972274 | Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study. |
| Q47350544 | Baseline insulin-like growth factor-I plasma levels, systemic inflammation, weight loss and clinical outcome in metastatic non-small cell lung cancer patients |
| Q33798652 | Better cancer specific survival in young small cell lung cancer patients especially with AJCC stage III |
| Q52983557 | CT scan prior to radiotherapy in unresectable, locally advanced, non-small cell carcinoma of the lung: is it always necessary? |
| Q33855122 | Characteristics of Mycobacterium avium complex (MAC) pulmonary disease in previously treated lung cancer patients |
| Q84582198 | Chemotherapy in stage III non-small cell lung cancer |
| Q64115321 | Clinical prognostic model for older patients with advanced non-small cell lung cancer |
| Q98210306 | Construction of a nomogram to predict the prognosis of non-small-cell lung cancer with brain metastases |
| Q93185088 | Contribution of programmed cell death 6 genetic variations, gender, and smoking status to lung cancer |
| Q38601725 | Current and Emerging Options in the Management of EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Considerations in the Elderly |
| Q35146940 | Customizing systemic therapy in patients with advanced non-small cell lung cancer |
| Q60048619 | Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study |
| Q47095890 | Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer |
| Q90318803 | Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients |
| Q38160089 | EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancer. |
| Q62127975 | EGFR exon mutation distribution and outcome in non-small-cell lung cancer: a Portuguese retrospective study |
| Q96133162 | Efficacy and Safety of Anlotinib in Advanced Non-Small Cell Lung Cancer: A Real-World Study |
| Q35549063 | Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies |
| Q42692908 | Exploring Stage I non-small-cell lung cancer: development of a prognostic model predicting 5-year survival after surgical resection†. |
| Q56770246 | FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2) |
| Q83396709 | Factors affecting survival time after recurrence of non-small-cell lung cancer treated with concurrent chemoradiotherapy |
| Q99582746 | Genomic characteristics in Chinese non-small cell lung cancer patients and its value in prediction of postoperative prognosis |
| Q35996748 | Glasgow prognostic score predicts prognosis of non-small cell lung cancer: a meta-analysis |
| Q52723567 | Histologic subtypes are not associated with the presence of sarcopenia in lung cancer. |
| Q44774245 | Histology as a potential clinical predictor of outcome in advanced non-small-cell lung cancer treated with vinorelbine and mitomycin combination chemotherapy |
| Q33775592 | Identification and validation of PROM1 and CRTC2 mutations in lung cancer patients |
| Q38323055 | Immunohistochemistry-based prognostic biomarkers in NSCLC: novel findings on the road to clinical use? |
| Q38367414 | Immunotherapy for lung cancer: for whom the bell tolls? |
| Q40269165 | Impact of Radiation Therapy in Surgically Resected Limited-Stage Small Cell Lung Carcinoma |
| Q37209610 | Impact of age on functional exercise correlates in patients with advanced lung cancer |
| Q36153407 | Impact of coexisting pulmonary diseases on survival of patients with lung adenocarcinoma: a STROBE-compliant article |
| Q40582776 | Impact of sex on prognostic host factors in surgical patients with lung cancer. |
| Q50323603 | Indicators for early assessment of palliative care in lung cancer patients: a population study using linked health data. |
| Q28303718 | International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma |
| Q60957987 | Management of Typical and Atypical Pulmonary Carcinoids Based on Different Established Guidelines |
| Q30827122 | Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests. |
| Q54943095 | New classification-new problems to solve. |
| Q92540152 | Non-invasive classification of non-small cell lung cancer: a comparison between random forest models utilising radiomic and semantic features |
| Q37874768 | Non-small-cell lung cancer. |
| Q38220335 | Novel treatment options in stage I non-small-cell lung cancer |
| Q40098978 | Outcomes of chemoradiation for patients with locally advanced non-small-cell lung cancer. |
| Q89848254 | Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non-Small-Cell Lung Cancer |
| Q37207053 | Pre-existing Pulmonary Diseases and Survival in Patients With Stage-dependent Lung Adenocarcinoma: A STROBE-compliant Article |
| Q36763839 | Prediagnosis soy food consumption and lung cancer survival in women |
| Q40305835 | Prediagnostic Calcium Intake and Lung Cancer Survival: A Pooled Analysis of 12 Cohort Studies |
| Q35996028 | Predicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age-challenges and opportunities |
| Q36070007 | Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed |
| Q34196497 | Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer |
| Q50050567 | Prognosis for non-small cell lung cancer patients with brain metastases |
| Q91633163 | Prognostic Value of Pretreatment Albumin-to-Alkaline Phosphatase Ratio in Extensive-Disease Small-Cell Lung Cancer: A Retrospective Cohort Study |
| Q41856545 | Prognostic effect of early treatment of paraneoplastic limbic encephalitis in a patient with small-cell lung cancer |
| Q33436297 | Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials |
| Q33697964 | Prognostic factors in resected lung carcinomas |
| Q37929588 | Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables |
| Q44484362 | Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish Descriptive Oncological Researches Group. |
| Q34324031 | Prognostic value of the ratio of ground glass opacity on computed tomography in small lung adenocarcinoma: A meta-analysis |
| Q35022194 | Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the Eur |
| Q34041808 | Prospective study on the incidence of bone metastasis (BM) and skeletal-related events (SREs) in patients (pts) with stage IIIB and IV lung cancer-CSP-HOR 13. |
| Q41491972 | Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer. |
| Q38915283 | Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parameters. |
| Q43884883 | Reevaluation of survival and prognostic factors in pathologic stage I lung adenocarcinoma by the new 2009 TNM classification |
| Q36258014 | Refining Prognosis in Lung Cancer: A Report on the Quality and Relevance of Clinical Prognostic Tools |
| Q35202454 | Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry |
| Q39229999 | Results of platinum-based chemotherapy in unselected performance status (PS) 2 patients with advanced non-small cell lung cancer: a cohort study |
| Q92651061 | Salvage treatment with anlotinib for advanced non-small cell lung cancer |
| Q34589991 | Simultaneous multi-antibody staining in non-small cell lung cancer strengthens diagnostic accuracy especially in small tissue samples |
| Q87755362 | Small cell lung cancer: what are the treatment results in routine management? |
| Q84084759 | Small-cell lung cancer |
| Q43416488 | Survival Differences by Gender for Resected Non-small Cell Lung Cancer: A Retrospective Analysis of 12,509 Cases in a Japanese Lung Cancer Registry Study |
| Q38438181 | Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients |
| Q89456290 | Survival prediction models for patients with anal carcinoma receiving definitive chemoradiation: A population-based study |
| Q33399979 | The IASLC lung cancer staging project. Comparing the current 6(th) TNM edition with the proposed 7(th) edition |
| Q53462930 | The International Association for the Study of Lung Cancer Staging Project. Prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer |
| Q92480471 | The MyoD family inhibitor domain-containing protein enhances the chemoresistance of cancer stem cells in the epithelial state by increasing β-catenin activity |
| Q38828542 | The Utility of Exercise Testing in Patients with Lung Cancer |
| Q54313517 | The effect of gefitinib in patients with postoperative recurrent non-small cell lung cancer harboring mutations of the epidermal growth factor receptor. |
| Q34988362 | The impact of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the risk and prognosis of portuguese patients with non-small cell lung cancer |
| Q92640094 | The impact of quantitative CT-based tumor volumetric features on the outcomes of patients with limited stage small cell lung cancer |
| Q45952058 | The increment in standardized uptake value determined using dual-phase 18F-FDG PET is a promising prognostic factor in non-small-cell lung cancer. |
| Q37944931 | The science behind the 7th edition Tumour, Node, Metastasis staging system for lung cancer |
| Q38555848 | The seventh tumour-node-metastasis staging system for lung cancer: Sequel or prequel? |
| Q35667908 | Variables affecting survival after second primary lung cancer: A population-based study of 187 Hodgkin's lymphoma patients |
| Q64884192 | [Anatomy, biology and concepts, pertaining to lung cancer stage classification]. |
Search more.